Telomir Share Price

Telomir Share Price

NASDAQ: TELO | Micro Cap | Healthcare
$0.42
-$0.00 (-0.59%) Last updated on 19 Nov, 2026 | 01:12 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Telomir Stock Performance

Open
$0.43
Prev. Close
$0.42
Circuit Range
N/A
Day Range
$0.42 - $0.44
Year Range
$0.42 - $1.58
Volume
500
Average Traded
$0.43

Telomir Share Price Today

As of 19 November 2026, Telomir Pharmaceuticals, Inc.'s share price is $0.42. The stock opened at $0.43, compared to its previous close of $0.42. During today's trading session, Telomir Pharmaceuticals, Inc.'s share price traded between $0.42 and $0.44, with an average price of $0.43. Over the past 52 weeks, the stock has recorded a high of $1.58 and a low of $0.42. In terms of performance, Telomir Pharmaceuticals, Inc.'s share price has declined by 67.52% over the last six months and is down 68.61% on a year-on-year basis.

Telomir Share Price Chart

Line chart of the Telomir price trend over the selected period. The price fell overall, ranging from 0.42 to 0.44, ending at 0.42.
$0.42$0.44
L
Show Current Price
H

Telomir Stock Fundamentals & Key Indicators

Market Cap
$13.31M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.70
Revenue (TTM)
$0.00
Return On Equity (TTM)
-1171.34%
Profit Margin
N/A
Debt to Equity
0.02
Quarterly Earnings Growth YoY
65.53%

Telomir Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$2.06-$0.99-$47.84-$0.71
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A51.94%-4732.32%98.52%

Telomir Annual Profit & Loss

All figures in USD

Particulars20242025
Revenue$0.00$0.00
Net Profit-$16.53-$10.41
Net Profit MarginN/AN/A
Income ChangeN/A37.02%

Telomir Balance Sheet

All figures in USD Million

Particulars20252024
Non Current Assets0.00.0
Current Assets7.341.32
Total Assets7.341.32
Non Current Liabilities0.00.0
Current Liabilities1.430.68
Total Liabilities1.430.68
Shareholders' Equity5.910.64

Telomir Cash Flow

Annually
Particulars20252024
Operating (USD Million)-3.69-5.07
Investing (USD Billion)0.00.0
Financing (USD Million)9.716.34

About Telomir

Telomir Pharmaceuticals Inc is a preclinical-stage biotechnology company focused on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases rather than treating symptoms alone. The company's research targets fundamental cellular processes associated with disease progression and functional decline, including metal-ion dysregulation, oxidative stress, epigenetic regulation, mitochondrial dysfunction, and telomere integrity. Telomir's investigational compound, Telomir-1 (Zn-Telomir), is a novel orally administered small molecule engineered to modulate intracellular metal balance particularly iron, copper, calcium, and zinc.

Telomir Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.93
$0.42
-53.54%
Oct 2026
$1.17
$0.90
-23.39%
Sep 2026
$1.18
$1.18
+0.00%
Aug 2026
$1.22
$1.18
-3.28%
Jul 2026
$1.29
$1.22
-3.94%
Jun 2026
$1.24
$1.27
-1.93%
May 2026
$1.41
$1.29
-8.16%
Apr 2026
$1.25
$1.41
+10.16%
Mar 2026
$1.20
$1.28
-3.03%
Feb 2026
$1.17
$1.32
+14.78%
Jan 2026
$1.32
$1.15
-13.53%
Dec 2025
$1.31
$1.33
-0.75%

Telomir Share Price FAQs